NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors who purchased BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ:BIOA) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.
The lawsuit was filed on behalf of investors who acquired BioAge securities from September 22, 2024, through January 7, 2025 (“the Class Period”). Investors have until March 10, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
The complaint alleges that defendants, in the IPO documents and throughout the Class Period, made false and/or materially misleading information regarding its STRIDES Phase 2 clinical trial.
[LEARN MORE ABOUT THE CLASS ACTION]
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com
